Company Profile
VYNE Therapeutics Inc. Stock Price, News & Analysis
- Ticker:
- VYNE
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
28.56 USD (+12.22%)
Close
Last updated: July 27, 2026
22.5M USD
Market cap
Why the stock is moving
Current closing-price context is not available for VYNE.
Company overview
Business overview
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology. Its story is built around developing specialized therapies for dermatologic conditions.
Geographic Base and Sector Classification
VYNE is headquartered in the United States and listed on NASDAQ. It sits in specialty dermatology biotechnology.
Business Model Characteristics
The company depends on clinical progress, formulation or mechanism differentiation, and capital efficiency. Investors typically watch data updates and the company's ability to sharpen its dermatology franchise.
Position Within the Biotechnology Landscape
VYNE occupies a focused dermatology niche within biotech. The stock is driven by whether its skin-disease programs can create durable differentiation.
Future catalysts
VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.
Recent news
- 01
- 02
- 03
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Source: VYNE Therapeutics Inc.
- 04
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
Source: VYNE Therapeutics Inc.
- 05
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
Source: VYNE Therapeutics Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of VYNE Therapeutics Inc. (VYNE)?
VYNE Therapeutics Inc. (VYNE) most recently closed at 28.56 USD, a +12.22% move versus the previous session.
What is the market cap of VYNE Therapeutics Inc. (VYNE)?
VYNE Therapeutics Inc. currently has a market capitalization of 22.5M USD on BioPharmSignal.
What does VYNE Therapeutics Inc. do?
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology. Its story is built around developing specialized therapies for dermatologic conditions.
On which exchange is VYNE stock listed?
VYNE Therapeutics Inc. (VYNE) is associated with NASDAQ, United States, Biopharma.
What is Therapeutics?
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology.
Which conditions is VYNE Therapeutics Inc. targeting with Therapeutics?
VYNE Therapeutics Inc. is associated with immunology, dermatology based on its company overview and current catalyst commentary.
How does VYNE Therapeutics Inc. describe recent progress with Therapeutics?
VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.
What future catalysts are investors watching for VYNE Therapeutics Inc.?
VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.